Delivery Order SPE2DB22D3004-SPE2DB25FSC70
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,013.96 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, an extended-release opioid pain medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,979.28 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded delivery order reflects firm fixed pricing and was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,810.39 for 60-count tablets of Nucynta ER 50 mg, an opioid pain management medication. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a prescription opioid medication used for pain management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 15, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg with a ceiling value of $2,121.93. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,805.53 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a opioid pain management medication. This non-set-aside, firm fixed-price delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,670.65 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, an extended-release opioid pain medication. This non-set-aside, firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a delivery order valued at $1,532.24 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 50 mg, a narcotic pain management medication. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication, with a contract ceiling value of $2,411.52. This is a firm fixed-price delivery order issued on August 6, 2025, with an ultimate completion date of August 7, 2025, with no set-aside designation. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSC70Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,010.63 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a prescription opioid pain management medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/21/25 |